Hearing diabetes in a one-minute electrocardiogram: Why phenotype-stratified machine learning may outperform one-size-fits-all screening

Abstract

Undiagnosed diabetes mellitus (DM) remains common, and scalable screening approaches that can be deployed beyond laboratory testing are urgently needed. In the recent issue of World Journal of Cardiology, Karbovskaya et al report a machine learning strategy to detect DM from a one-minute, single-lead electrocardiogram (ECG) acquired with a portable device in 629 participants, addressing a central barrier to ECG-based DM detection: Confounding by coexisting cardiovascular disease (CVD). Rather than treating the population as homogeneous, the investigators used phenotypic clustering of clinical profiles and a cluster-stratified validation scheme (training on three clusters and testing on the fourth) to identify where DM-specific ECG signatures are most discernible. Performance concentrated in a comorbidity-burdened, high-DM phenotype (cluster 4), with sensitivity 75%, specificity 83%, and area under the curve 0.88, suggesting that “precision screening” may be a more realistic paradigm than universal classifiers. This editorial highlights the study’s key contribution, explicitly modeling phenotype to mitigate CVD confounding, while emphasizing the translational prerequisites for impact: External, multi-center validation; assessment of calibration and workflow utility; and careful attention to device-specific, proprietary feature extraction and modest cluster sizes that may limit portability. If replicated, phenotype-targeted single-lead ECG could serve as a low-cost triage tool to trigger confirmatory glycemic testing in high-risk settings.

Keywords: Diabetes mellitus; Machine learning; Electrocardiography; Digital biomarkers; Single-lead electrocardiogram

Core Tip: A one-minute, single-lead electrocardiogram (ECG) may enable scalable screening for diabetes mellitus (DM) when paired with machine learning. Karbovskaya et al introduced a phenotype-clustering strategy that explicitly accounts for clinical heterogeneity and cardiovascular comorbidity, revealing that DM-related ECG signatures are most detectable in specific patient subgroups rather than uniformly across populations. By emphasizing interpretable electrophysiologic features and testing model transportability across phenotypes, this work advances a “precision screening” paradigm and provides a practical roadmap for translating ECG-based metabolic risk detection into real-world cardiometabolic workflows.